We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Stock Sinks As Market Gains: Here's Why
Read MoreHide Full Article
Tenet Healthcare (THC - Free Report) closed the most recent trading day at $211.64, moving -3.49% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.25%. Meanwhile, the Dow gained 0.1%, and the Nasdaq, a tech-heavy index, added 0.47%.
Prior to today's trading, shares of the hospital operator had lost 5.11% lagged the Medical sector's loss of 4.79% and the S&P 500's loss of 1.88%.
The investment community will be paying close attention to the earnings performance of Tenet Healthcare in its upcoming release. It is anticipated that the company will report an EPS of $4.19, marking a 3.9% fall compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $5.39 billion, reflecting a 3.15% rise from the equivalent quarter last year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $17.3 per share and a revenue of $21.99 billion, representing changes of +3.1% and +3.21%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Tenet Healthcare. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 1.76% higher. Tenet Healthcare is holding a Zacks Rank of #3 (Hold) right now.
In terms of valuation, Tenet Healthcare is currently trading at a Forward P/E ratio of 12.68. This expresses no noticeable deviation compared to the average Forward P/E of 12.68 of its industry.
We can also see that THC currently has a PEG ratio of 1.06. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. THC's industry had an average PEG ratio of 1.06 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. This group has a Zacks Industry Rank of 56, putting it in the top 23% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Tenet Healthcare (THC) Stock Sinks As Market Gains: Here's Why
Tenet Healthcare (THC - Free Report) closed the most recent trading day at $211.64, moving -3.49% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.25%. Meanwhile, the Dow gained 0.1%, and the Nasdaq, a tech-heavy index, added 0.47%.
Prior to today's trading, shares of the hospital operator had lost 5.11% lagged the Medical sector's loss of 4.79% and the S&P 500's loss of 1.88%.
The investment community will be paying close attention to the earnings performance of Tenet Healthcare in its upcoming release. It is anticipated that the company will report an EPS of $4.19, marking a 3.9% fall compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $5.39 billion, reflecting a 3.15% rise from the equivalent quarter last year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $17.3 per share and a revenue of $21.99 billion, representing changes of +3.1% and +3.21%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Tenet Healthcare. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 1.76% higher. Tenet Healthcare is holding a Zacks Rank of #3 (Hold) right now.
In terms of valuation, Tenet Healthcare is currently trading at a Forward P/E ratio of 12.68. This expresses no noticeable deviation compared to the average Forward P/E of 12.68 of its industry.
We can also see that THC currently has a PEG ratio of 1.06. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. THC's industry had an average PEG ratio of 1.06 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. This group has a Zacks Industry Rank of 56, putting it in the top 23% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.